It is a broadly described annual report of Aurobindo Pharma Limited in the year of 2014-2015. During the financial year, Total assets of the Company stood at Rs. 129,144.8 million. In 2014-15, the revenues increased by 49.6% to Rs. 121,205.2 million. EBITDA for the year grew 23.4% and was Rs. 26,603.3 million as compared to Rs. 21,552.1 million in 2013-14. The Company posted Profit before Tax for the year at Rs. 21,678.5 million as against at Rs. 15,325.2 million in the previous year. The profit after tax for the financial year at Rs. 15,757.7 million as against at Rs. 11,728.5 million. The earnings per share of the Company for the year grew by 34.3% to Rs. 54.0.
The Board of Directors of the Company has recommended a dividend of @450% i.e. Rs. 4.50/- per share on the equity share of Rs. 1/- against @300% i.e. Rs. 3/- per share of Rs. 1/- paid in the previous year.
More Annual report of Aurobindo Pharma Limited:
